interferoninduc
transmembran
protein
antivir
transmembran
protein
thought
serv
primari
factor
inhibit
replic
al
arg
number
virus
nclude
west
nile
viru
engu
viru
ebola
viru
zika
virusproduct
kda
transmembran
protein
especi
essenti
posttransl
modif
b
yr
ecombin
express
challenginginthi
report
document
chemic
synthesi
multimilligram
quantiti
mg
prepar
phosphoryl
fluoresc
variantst
synthesi
accomplish
use
kaha
ligat
w
hich
oper
acid
aqueousorgan
mixtur
excel
solubil
even
except
hydrophob
ctermin
region
synthet
materi
readili
incorpor
model
vesicl
form
basi
use
synthet
h
omogen
deriv
studi
structur
biolog
mode
action
interferoninduc
transmembran
protein
amino
acid
membraneassoci
protein
mp
inhibit
replic
pathogen
virusesthi
protein
first
name
fragili
report
saitou
cowork
interest
surg
antivir
properti
came
light
influenza
pandem
everitt
cowork
report
patient
lack
full
quickli
sever
infect
lead
adramat
increas
mortal
ubsequ
studi
shown
exhibit
antivir
activ
al
arg
number
virus
includ
west
nile
viru
dengu
viru
filovirus
ebola
marburg
virus
sar
coronaviru
rift
va
lley
fever
viru
recent
zika
viru
relat
protein
ifitm
contain
two
highli
hydrophob
intramembran
domain
aconserv
loop
region
amor
polar
ntermin
region
vari
sequenc
length
figur
sever
propos
structur
embranespan
topolog
nd
mechan
action
report
littl
consensu
prevent
viral
replic
studi
structur
determin
investig
numer
posttransl
modif
hamper
part
lack
access
pure
protein
especi
homogen
materi
contain
essenti
posttransl
modif
report
document
product
milligram
quantiti
homogen
key
posttransl
modifi
variant
total
chemic
synthesi
use
aketoacidhydroxylamin
kaha
ligat
key
success
work
uniqu
natur
kaha
ligat
use
w
hich
oper
acid
condit
ideal
solubil
hydrophob
peptid
segment
deliv
solubl
peptid
ester
compar
amid
primari
ligat
product
theu
se
result
introduct
homoserin
anoncanon
amino
acid
ligat
sitew
hen
care
chosen
found
innocu
mutat
mani
residu
shown
disturb
fold
biolog
activ
the
ynthetic
rout
allow
facil
incorpor
key
posttransl
modif
nclude
phosphoryl
attach
afluoresc
dyethi
work
establish
access
homogen
enabl
studi
structur
mode
action
synthet
plan
took
account
differ
structur
region
took
inspir
amap
key
residu
construct
brass
cowork
aim
synthes
three
segment
use
two
kaha
ligationsf
first
ligat
site
w
ec
hose
inc
locat
expos
loop
region
show
consider
variabl
among
ifitm
protein
second
ligat
select
inc
site
report
one
variabl
site
within
otherwis
highli
conserv
region
strategi
call
use
av
alin
aketoacid
ligat
although
somewhat
slower
less
hinder
residu
h
proven
excel
choic
kaha
ligat
the
ynthesi
segment
contain
domain
prove
challengingo
wing
extrem
hydrophob
wefirst
attempt
synthes
tertbutyloxycarbonyl
solidphas
peptid
synthesi
bocspp
sinc
boc
chemistri
known
better
suit
fluorenylmethyloxycarbonyl
solidphas
peptid
synthesi
fmocspp
prepar
hydrophob
supportinginform
orcid
identif
number
author
articl
found
http
abstract
interferoninduc
transmembran
protein
antivir
transmembran
protein
thought
serv
primari
factor
inhibit
replic
al
arg
number
virus
nclude
west
nile
viru
engu
viru
ebola
viru
zika
virusproduct
kda
transmembran
protein
especi
essenti
posttransl
modif
b
yr
ecombin
express
challenginginthi
report
document
chemic
synthesi
multimilligram
quantiti
mg
prepar
phosphoryl
fluoresc
variantst
synthesi
accomplish
use
kaha
ligat
w
hich
oper
acid
aqueousorgan
mixtur
excel
solubil
even
except
hydrophob
ctermin
region
synthet
materi
readili
incorpor
model
vesicl
form
basi
use
synthet
h
omogen
deriv
studi
structur
biolog
mode
action
interferoninduc
transmembran
protein
amino
acid
membraneassoci
protein
mp
inhibit
replic
pathogen
virusesthi
protein
first
name
fragili
report
saitou
cowork
interest
surg
antivir
properti
came
light
influenza
pandem
everitt
cowork
report
patient
lack
full
quickli
sever
infect
lead
adramat
increas
mortal
ubsequ
studi
shown
exhibit
antivir
activ
al
arg
number
virus
includ
west
nile
viru
dengu
viru
filovirus
ebola
marburg
virus
sar
coronaviru
rift
va
lley
fever
viru
recent
zika
viru
relat
protein
ifitm
contain
two
highli
hydrophob
intramembran
domain
aconserv
loop
region
amor
polar
ntermin
region
vari
sequenc
length
figur
sever
propos
structur
embranespan
topolog
nd
mechan
action
report
littl
consensu
prevent
viral
replic
studi
structur
determin
investig
numer
posttransl
modif
hamper
part
lack
access
pure
protein
especi
homogen
materi
contain
essenti
posttransl
modif
report
document
product
milligram
quantiti
homogen
key
posttransl
modifi
variant
total
chemic
synthesi
use
aketoacidhydroxylamin
kaha
ligat
key
success
work
uniqu
natur
kaha
ligat
use
w
hich
oper
acid
condit
ideal
solubil
hydrophob
peptid
segment
deliv
solubl
peptid
ester
compar
amid
primari
ligat
product
theu
se
result
introduct
homoserin
anoncanon
amino
acid
ligat
sitew
hen
care
chosen
found
innocu
mutat
mani
residu
shown
disturb
fold
biolog
activ
the
ynthetic
rout
allow
facil
incorpor
key
posttransl
modif
nclude
phosphoryl
attach
afluoresc
dyethi
work
establish
access
homogen
enabl
studi
structur
mode
action
synthet
plan
took
account
differ
structur
region
took
inspir
amap
key
residu
construct
brass
cowork
aim
synthes
three
segment
use
two
kaha
ligationsf
first
ligat
site
w
ec
hose
inc
locat
expos
loop
region
show
consider
variabl
among
ifitm
protein
second
ligat
select
inc
site
report
one
variabl
site
within
otherwis
highli
conserv
region
strategi
call
use
av
alin
aketoacid
ligat
although
somewhat
slower
less
hinder
residu
h
proven
excel
choic
kaha
ligat
the
ynthesi
segment
contain
domain
prove
challengingo
wing
extrem
hydrophob
wefirst
attempt
synthes
tertbutyloxycarbonyl
solidphas
peptid
synthesi
bocspp
sinc
boc
chemistri
known
better
suit
fluorenylmethyloxycarbonyl
solidphas
peptid
synthesi
fmocspp
prepar
hydrophob
peptid
unfortun
attempt
purifi
peptid
obtain
hf
cleavag
unsuccess
next
attempt
synthesi
segment
howev
even
less
effici
residu
amount
impur
greater
desir
product
thea
ddition
solubil
tag
backbon
protect
report
improv
synthesi
hydrophob
peptid
decid
employ
oligoarginin
tag
argtag
imilar
one
describ
wade
cowork
remov
basic
treatment
room
temperaturet
tag
present
two
advantag
f
irst
oligoarginin
shown
greatli
increas
solubl
hydrophob
sequenc
hu
make
handl
purif
segment
easier
econd
arginin
tag
attach
cterminu
rather
backbon
peptid
thu
facilit
synthesi
incorpor
peptidew
ith
strategi
f
mocspp
hydrophob
segment
proceed
smoothli
nd
cleav
peptid
bear
arg
tag
could
readili
purifi
reversephas
hplct
synthesi
one
gram
resin
afford
mg
purifi
peptid
overal
yield
bear
ntermin
central
segment
bear
ac
termin
valin
aketoacid
prepar
fmocspp
nd
requisit
photoprotect
ethyl
carbamateopr
npecopr
introduc
final
residu
thefrag
join
first
kaha
ligat
pleas
find
segment
perfectli
solubl
nmph
omixtur
mmdespit
use
hinder
valin
aketoacid
ligat
almost
complet
h
time
ag
el
form
ther
eaction
mixtur
dilut
mm
nmp
left
addit
hb
ut
chang
observ
thu
indic
ligat
reaction
reach
maximum
convers
ligat
mixtur
dilut
cnh
ocontain
fa
odt
ethylenedioxi
diethanethiol
ad
result
mixtur
stir
handheld
uv
light
nm
min
remov
npec
groupth
reaction
mixtur
directli
purifi
hplc
afford
desir
ligat
peptid
overal
yield
figur
thesecond
final
ligat
perform
peptid
equiv
h
mm
amixtur
nmph
thel
igat
somewhat
slower
typic
observ
hagel
form
ligat
proceed
beyond
c
onvers
despit
gel
format
desir
ligat
product
cleanli
form
ixtur
dilut
mm
carbon
buffer
ph
left
effect
n
acyl
shift
two
homoserin
ester
concentr
purif
hplc
w
e
isol
mg
ield
desir
f
igur
the
ynthetic
bear
ctermin
argtag
character
hplc
h
rm
sdspage
forc
ds
pectroscopi
protein
incorpor
phosphatidylcholin
pc
lipid
vesicl
spectra
show
trong
ahelix
fingerprint
accord
calcul
structur
figur
releas
protein
ctermin
solubil
tag
p
rotein
treat
naoh
howev
decomposit
protein
observ
part
hydrolysi
overcom
problem
pursu
altern
approach
remov
arg
tag
prior
final
ligat
figur
first
ligat
uv
irradi
reaction
mixtur
dilut
naoh
solut
ac
oncentr
naoh
reach
solut
cool
ice
bath
slowli
quench
olut
fa
water
directli
purifi
hplc
afford
desir
ield
tep
figur
remov
argtag
basic
condit
gave
asingl
peak
hplc
thefin
ligat
without
solubil
group
perform
use
n
mp
aqueou
oxal
acid
despit
hydrophob
segment
ligat
proceed
rel
well
follow
dilut
ligat
mixtur
mm
acarbon
buffer
ph
stir
nshift
mg
unmodifi
isol
prepar
hplc
ah
eat
column
figur
cd
spectra
measur
follow
procedur
beforet
cd
spectra
show
trong
fingerprint
ahelix
conform
thet
wo
cd
spectra
nearli
ident
thu
show
ctermin
argtag
influenc
structur
figur
first
attempt
measur
ms
protein
lack
solubil
tag
unsuccess
imilar
problem
note
liu
cowork
synthesi
multidrugresist
transport
emr
anoth
membran
protein
ration
highli
hydrophob
natur
protein
pauciti
ioniz
sitesw
esucceed
character
protein
digest
acid
condit
analysi
result
fragment
maldimst
procedur
gave
sequenc
coverag
confirm
synthesi
full
protein
figur
sever
studi
establish
posttransl
modif
essenti
antivir
activ
ther
ole
numer
modif
remain
ubject
debat
nd
inabl
prepar
isol
homogen
protein
complic
effortsa
key
advantag
chemic
protein
synthesi
abil
esim
spectra
isol
fragment
green
triangl
highlight
calibr
peak
c
hplc
trace
purifi
cd
spectra
analysi
reconstitut
pc
micel
grey
cd
spectra
analysi
reconstitutedi
n
pc
micel
green
mm
cell
e
sdspagecoomassi
stain
sequenc
analysi
maldimsofovernight
acid
digest
show
asequ
coverag
precis
control
presenc
absenc
posttransl
modif
aswel
power
incorpor
probe
affin
tag
fluoresc
dye
facilit
biochem
biophys
studi
initi
effort
use
synthet
rout
deriv
w
ef
ocus
one
import
posttransl
modif
p
hosphoryl
tyrosin
addit
prepar
af
luoresc
label
studi
incorpor
membran
vesiclesw
ehad
previous
attempt
kaha
ligat
phosphoryl
peptidesour
strategi
requir
phosphotyrosin
stabl
oxid
condit
convers
phosphoryl
segment
yanosulfurylid
correspond
aketoacid
well
acid
condit
kaha
ligat
fort
prepar
segment
ontain
phosphotyr
choos
obenzylprotect
phosphotyr
fmocspp
w
hich
afford
unprotect
residu
upon
tfac
leavaget
segment
synthesi
proceed
smoothli
phosphotyr
stabl
sulfurylid
oxid
kaha
ligat
afford
ty
f
igur
sever
report
attribut
antivir
activ
abil
block
fusion
viral
membran
endosom
thea
ctiviti
therefor
depend
abil
local
cell
membran
order
use
variant
probe
mode
action
wish
incorpor
protein
amembran
mimet
chose
egg
phosphatidylcholin
tart
point
synthet
incub
vesicl
pass
sepharos
exclus
resin
insert
membran
vesicl
itshould
elut
larger
vesicl
smaller
nonincorpor
protein
retain
thef
lowthrough
lyophil
analyz
sdspage
chymotrypsinogen
aw
use
eg
control
shown
work
franci
cowork
pleas
observ
incorpor
lipid
membran
expect
forf
urther
confirm
synthet
incorpor
membran
w
ep
repar
ah
segment
ntermin
carboxyfluorescein
fmocsppsr
esin
cleavag
xidat
cyanosulfurylid
nd
ligat
fford
protein
fluoresc
dyet
fluorophoremodifi
w
incorpor
mediums
vesicl
pass
sizeexclus
resin
observ
fluoresc
microscopya
ss
hown
figur
clearli
local
membran
vesicl
asexpect
previou
experi
conclus
develop
effici
chemic
synthesi
pure
ultimilligram
scale
make
use
kaha
ligat
approach
provid
facil
access
bear
natur
posttransl
modif
well
deriv
possibl
prepar
current
recombin
approachest
uniqu
featur
kaha
ligat
includ
abil
oper
acid
condit
ts
toler
organ
cosolv
nd
format
solubl
depsipeptid
ligat
site
ake
ideal
method
chemic
synthesi
membran
proteinst
work
also
establish
kaha
ligat
compat
phosphoryl
peptid
segment
provid
access
import
posttransl
modificationst
materi
produc
rout
use
ongo
studi
role
variant
restrict
entri
influenza
aviru
